Rhizoma coptidis inhibits LPS-induced MCP-1/CCL2 production in murine macrophages via an AP-1 and NF B-dependent pathway

Mediators of Inflammation

Volumn 2010, Issue , 2010, Pages

  Remppis, Andrew ^a   Bea, Florian ^a   Greten, Henry Johannes ^b,c   Buttler, Annette ^a   Wang, Hongjie ^a   Zhou, Qianxing ^a   Preusch, Michael R ^d   Enk, Ronny ^a   Ehehalt, Robert ^a   Katus, Hugo ^a   Blessing, Erwin ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b Deutsche Gesellschaft für Traditionelle Chinesische Medizin DGTCM   (Germany)

^c UNIVERSITY OF PORTO   (Portugal)

^d UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BERBERINE; COPTIS RHIZOME EXTRACT; FLUINDOSTATIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIPOPOLYSACCHARIDE; MONOCYTE CHEMOTACTIC PROTEIN 1; OLMESARTAN; PLANT EXTRACT; ROSUVASTATIN; TELMISARTAN; TRANSCRIPTION FACTOR AP 1; ANTIINFLAMMATORY AGENT; CCL2 PROTEIN, MOUSE; HERBACEOUS AGENT; INTERLEUKIN 12; INTERLEUKIN 1BETA; NITRIC OXIDE; REACTIVE OXYGEN METABOLITE;

ANIMAL CELL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL LINE; CELL STIMULATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; IN VITRO STUDY; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RHIZOMA COPTIDIS; RHIZOME; SIGNAL TRANSDUCTION; ANIMAL; BIOSYNTHESIS; CELL CULTURE; DRUG ANTAGONISM; DRUG EFFECT; METABOLISM; PHYSIOLOGY;

MURINAE;

ANIMALS; ANTI-INFLAMMATORY AGENTS; BERBERINE; CELLS, CULTURED; CHEMOKINE CCL2; DRUGS, CHINESE HERBAL; INTERLEUKIN-12; INTERLEUKIN-1BETA; LIPOPOLYSACCHARIDES; MACROPHAGES; MICE; NF-KAPPA B; NITRIC OXIDE; REACTIVE OXYGEN SPECIES; TRANSCRIPTION FACTOR AP-1;

EID: 77955406469     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/2010/194896     Document Type: Article

References (28)

1. Gao Z., Leng S., Lu F., Xie M., Xu L., Wang K., Effect of berberine on expression of hepatocyte nuclear factor-4 in rats with fructose-induced insulin resistance Journal of Huazhong University of Science and TechnologyMedical Science 2008 28 3 261 265
2. Wang Y., Huang Y., Lam K. S. L., Li Y., Wong W. T., Ye H., Lau C.-W., Vanhoutte P. M., Xu A., Berberine prevents hyperglycemia-induced endothelial injury and enhances vasodilatation via adenosine monophosphate-activated protein kinase and endothelial nitric oxide synthase Cardiovascular Research 2009 82 3 484 492
3. Yin J., Zhang H., Ye J., Traditional Chinese medicine in treatment of metabolic syndrome Endocrine, Metabolic and Immune Disorders: Drug Targets 2008 8 2 99 111
4. Zhou J., Zhou S., Tang J., Zhang K., Guang L., Huang Y., Xu Y., Ying Y., Zhang L., Li D., Protective effect of berberine on beta cells in streptozotocin- and high-carbohydrate/high-fat diet-induced diabetic rats European Journal of Pharmacology 2009 606 13 262 268
5. Kong W., Wei J., Abidi P., Lin M., Inaba S., Li C., Wang Y., Wang Z., Si S., Pan H., Wang S., Wu J., Wang Y., Li Z., Liu J., Jiang J.-D., Berberine is a novel cholesterol-lowering drug working through a unique mechanism distinct from statins Nature Medicine 2004 10 12 1344 1351
6. Enk R., Ehehalt R., Graham J. E., Bierhaus A., Remppis A., Greten H. J., Differential effect of Rhizoma coptidis and its main alkaloid compound berberine on TNF- induced NF B translocation in human keratinocytes Journal of Ethnopharmacology 2007 109 1 170 175
7. Lin J.-P., Yang J.-S., Wu C.-C., Lin S.-S., Hsieh W.-T., Lin M.-L., Yu F.-S., Yu C.-S., Chen G.-W., Chang Y.-H., Chung J.-G., Berberine induced down-regulation of matrix metalloproteinase-1, -2 and -9 in human gastric cancer cells (SNU-5) in vitro In Vivo 2008 22 2 223 230
8. Ho Y.-T., Yang J.-S., Li T.-C., Lin J.-J., Lin J.-G., Lai K.-C., Ma C.-Y., Wood W. G., Chung J.-G., Berberine suppresses in vitro migration and invasion of human SCC-4 tongue squamous cancer cells through the inhibitions of FAK, IKK, NF- B, u-PA and MMP-2 and -9 Cancer Letters 2009 279 2 155 162
9. Kim S., Choi J. H., Kim J. B., Seok J. N., Yang J.-H., Kim J.-H., Jeong E. L., Berberine suppresses TNF- -induced MMP-9 and cell invasion through inhibition of AP-1 activity in MDA-MB-231 human breast cancer cells Molecules 2008 13 12 2975 2985
10. Fukuda K., Hibiya Y., Mutoh M., Koshiji M., Akao S., Fujiwara H., Inhibition of activator protein 1 activity by berberine in human hepatoma cells Planta Medica 1999 65 4 381 383 (Pubitemid 29249921)
11. Liang K.-W., Ting C.-T., Yin S.-C., Chen Y.-T., Lin S.-J., Liao J. K., Hsu S.-L., Berberine suppresses MEK/ERK-dependent Egr-1 signaling pathway and inhibits vascular smooth muscle cell regrowth after in vitro mechanical injury Biochemical Pharmacology 2006 71 6 806 817
12. Liang K.-W., Yin S.-C., Ting C.-T., Lin S.-J., Hsueh C.-M., Chen C.-Y., Hsu S.-L., Berberine inhibits platelet-derived growth factor-induced growth and migration partly through an AMPK-dependent pathway in vascular smooth muscle cells European Journal of Pharmacology 2008 590 13 343 354
13. Hsiang C.-Y., Wu S.-L., Cheng S.-E., Ho T.-Y., Acetaldehyde-induced interleukin-1 and tumor necrosis factor- production is inhibited by berberine through nuclear factor- B signaling pathway in HepG2 cells Journal of Biomedical Science 2005 12 5 791 801
14. Lu J.-S., Liu Y.-Q., Li M., Li B.-S., Xu Y., Protective effects and its mechanisms of total alkaloids from rhizoma Coptis chinensis on Helicobacter pylori LPS induced gastric lesion in rats Zhongguo Zhongyao Zazhi 2007 32 13 1333 1336
15. Park E.-K., Rhee H. I., Jung H.-S., Seoung M. J., Lee Y.-A., Lee S.-H., Hong S.-J., Yang H.-I., Yoo M.-C., Kim K. S., Antiinflammatory effects of a combined herbal preparation (RAH13) of Phellodendron amurense and Coptis chinensis in animal models of inflammation Phytotherapy Research 2007 21 8 746 750
16. Hoppe-Seyler F., Butz K., Rittmuller C., von Knebel Doeberitz M., A rapid microscale procedure for the simultaneous preparation of cytoplasmic RNA, nuclear DNA binding proteins and enzymatically active luciferase extracts Nucleic Acids Research 1991 19 18 5080
17. Liu J., He C., Zhou K., Wang J., Kang J. X., Coptis extracts enhance the anticancer effect of estrogen receptor antagonists on human breast cancer cells Biochemical and Biophysical Research Communications 2009 378 2 174 178
18. Hsieh Y.-S., Kuo W.-H., Lin T.-W., Chang H.-R., Lin T.-H., Chen P.-N., Chu S.-C., Protective effects of berberine against low-density lipoprotein (LDL) oxidation and oxidized LDL-induced cytotoxicity on endothelial cells Journal of Agricultural and Food Chemistry 2007 55 25 10437 10445
19. Huang Z., Wang L., Meng S., Wang Y., Chen T., Wang C., Berberine reduces both MMP-9 and EMMPRIN expression through prevention of p38 pathway activation in PMA-induced macrophages. International Journal of Cardiology, July 2. In press
20. Chen F. L., Yang Z. H., Liu Y., Li L. X., Liang W. C., Wang X. C., Zhou W. B., Yang Y. H., Hu R. M., Berberine inhibits the expression of TNFalpha, MCP-1, and IL-6 in AcLDL-stimulated macrophages through PPARgamma pathway Endocrine 2008 33 3 331 337
21. Kim K.-W., Ha K.-T., Park C.-S., Jin U.-H., Chang H. W., Lee I.-S., Kim C.-H., Polygonum cuspidatum, compared with baicalin and berberine, inhibits inducible nitric oxide synthase and cyclooxygenase-2 gene expressions in RAW 264.7 macrophages Vascular Pharmacology 2007 47 2-3 99 107
22. Jeong H. W., Hsu K. C., Lee J.-W., Ham M., Huh J. Y., Shin H. J., Kim W. S., Kim J. B., Berberine suppresses proinflammatory responses through AMPK activation in macrophages American Journal of Physiology 2009 296 4 E955 E964
23. Ross R., Atherosclerosisan inflammatory disease The New England Journal of Medicine 1999 340 2 115 126
24. Yan Z.-Q., Hansson G. K., Innate immunity, macrophage activation, and atherosclerosis Immunological Reviews 2007 219 1 187 203
25. Ko Y. J., Lee J.-S., Park B. C., Shin H. M., Kim J.-A., Inhibitory effects of Zoagumhwan water extract and berberine on angiotensin II-induced monocyte chemoattractant protein (MCP)-1 expression and monocyte adhesion to endothelial cells Vascular Pharmacology 2007 47 2-3 189 196
26. Chen F. L., Yang Z. H., Liu Y., Li L. X., Liang W. C., Wang X. C., Zhou W. B., Yang Y. H., Hu R. M., Berberine inhibits the expression of TNFalpha, MCP-1, and IL-6 in AcLDL-stimulated macrophages through PPARgamma pathway Endocrine 2008 33 3 331 337
27. Li K., Yao W., Zheng X., Liao K., Berberine promotes the development of atherosclerosis and foam cell formation by inducing scavenger receptor a expression in macrophage Cell Research 2009 19 8 1006 1017
28. Li H., Dong B., Park S. W., Lee H.-S., Chen W., Liu J., Hepatocyte nuclear factor 1 plays a critical role in PCSK9 gene transcription and regulation by the natural hypocholesterolemic compound berberine Journal of Biological Chemistry 2009 284 42 28885 28895